Susceptibility of Pseudomonas aeruginosa to antimicrobials: A 2004 French multicentre hospital study

Journal of Antimicrobial Chemotherapy

Volumn 59, Issue 5, 2007, Pages 1021-1024

  Cavallo, J D ^a   Hocquet, D ^b   Plesiat, P ^b   Fabre, R ^a   Roussel Delvallez, M ^c  

^a SERVICE D ENDOCRINOLOGIE   (France)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

lactams; Antimicrobial resistance surveillance; Mechanisms of resistance; Pseudomonas spp.

Indexed keywords

AMIKACIN; AZTREONAM; BACTERIAL PROTEIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; BETA LACTAMASE AMPC; CEFEPIME; CEFTAZIDIME; CEPHALOSPORINASE; CIPROFLOXACIN; IMIPENEM; LEVOFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; PROTEIN MEXAB OPRM; TICARCILLIN; TIMENTIN; TOBRAMYCIN; UNCLASSIFIED DRUG;

AGAR GEL DIFFUSION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; FRANCE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTEIN DETERMINATION; PSEUDOMONAS AERUGINOSA; UNIVERSITY HOSPITAL;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMS; CEPHALOSPORINASE; FRANCE; HOSPITALS; HUMANS; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA;

EID: 34447567191     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm076     Document Type: Article

References (11)

1. Livermore DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: Our worst nightmare? Clin Infect Dis 2002; 34: 634-40.
2. Courvalin P, Soussy CJ. Technical recommendations for in vitro susceptibility testing. Clin Microbiol Infect 1996; 2 Suppl 1: 511-22.
3. Comité de l'Antibiogramme do la Société Française de Microbiologie. Communiqué 2006. http://www.sfm.asso.fr.
4. Cavallo JD, Fabre R, Leblanc F et al. Antibiotic susceptibility and mechanisms of β-lactam resistance in 1310 strains of Pseudomonas aeruginosa: A French multicentre study 1996. J Antimicrob Chemother 2000; 46: 133-6.
5. Barthélémy M, Guionie M, Labia R. β-Lactamases: Determination of their isoelectric points. Antimicrob Agents Chemother 1978; 13 695-8.
6. Hocquet D, Nordmann P, El Garch F et al., Involvement of the efflux system MexXY-OprM in the emergence of cefepime resistance in clinical strains of Pseudomonas aeruginosa. Antimicrob Agents Chemother 2006; 50: 1347-51.
7. Cavallo JD, Leblanc F, Fabre R. Survey of the antibiotic susceptibility of Pseudomonas aeruginosa in France and the distribution of β-lactam resistance mechanisms: The GERPB study 1998. Pathol Biol 2000; 48: 472-7.
8. Cavallo JD, Leblanc F, Fabre R et al. Survey of the antibiotic susceptibility of Pseudomonas aeruginosa in France and the distribution of β-lactam resistance mechanisms: The GERPB study 1999. Pathol Biol 2001; 49: 534-9.
9. Hance P, Fabre R, Leblanc F et al. Correlation between sensitivity to fosfomycin and the presence of penicillinase PSE-1 in Pseudomonas aeruginosa. Pathol Biol 2001; 49: 12-5.
10. Cavallo JD, Plésiat P, Couetdic G et al. Mechanisms of β-lactam resistance in Pseudomonas aeruginosa: Prevalence of OprM-overproducing strains in a French multicentre study (1997). J Antimicrob Chemother 2002; 50: 1039-43.
11. Poole K. Efflux-mediated multiresistance in Gram-negative bacteria. Clin Microbiol Infect 2004; 10: 12-26.